✦ LIBER ✦

Infliximab: steroid-sparing effect in paediatric Crohn's disease

Book ID: 120860566
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200313760-00024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab is steroid-sparing in luminal

Infliximab is steroid-sparing in luminal Crohn's disease

✍ Cohen, Russell D.; Papalia, Patrizia; Hanauer, Stephen B. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Infliximab promising in paediatric Crohn

Infliximab promising in paediatric Crohn's disease

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Infliximab Paediatric Crohn’s Disease Ed

Infliximab Paediatric Crohn’s Disease Educational Plan

✍ Alejandro Arana, Sam Allen, Jörg Burkowitz, Valerio Fantoni, Ola Ghatnekar, Marí 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 293 KB

Infliximab appears to be beneficial in p

Infliximab appears to be beneficial in paediatric Crohn's disease,

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Infliximab in the treatment of Crohn’s d

Infliximab in the treatment of Crohn’s disease: is it a steroid sparing agent or a steroid replacing agent?

✍ Mark R. Fleisher; Steven D. Rubin; Andrew E. Levine; Alexander Burns; Kyle Etzko 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 29 KB

Infliximab effective in resistant Crohn’

Infliximab effective in resistant Crohn’s disease

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 207 KB